Use of Zebrafish as a Model for Diabetic Nephropathy

使用斑马鱼作为糖尿病肾病模型

基本信息

项目摘要

DESCRIPTION (provided by applicant): A thickening in basement membranes (BM) is a common secondary complication of diabetes and is associated with abnormalities in kidney function when the glomerular BM (GBM) is affected. While the mechanisms underlying GBM thickening are not understood, it is evident that the normal biosynthesis and maintenance of GBM is an important aspect of kidney function. GBM thickening can be explained in terms of problems in the balance of matrix component synthesis, polymerization, and turnover. These processes all involve cell/ECM interactions to some degree and imply that GBM formation is tightly controlled. To understand the mechanisms underlying GBM formation and maintenance under normal and pathological conditions, we propose to utilize the zebrafish (ZF) as a model system. The ZF lends itself to such studies because its renal system develops rapidly and the organism is amendable to cellular, molecular, and genetic approaches. The ZF renal system develops in two stages including: 1) formation of a transient pronephros by 50 hrs of development that is composed of a single glomerulus and 2) formation of a mesonephros by the 3d week that contains multiple glomeruli as seen in mammals. Unlike the pronephros, the ZF mesonephric kidney has not been well studied although it is required for studies related to GBM formation, maturation, and turnover. The specific aims of this two-year R21 (Exploratory/Developmental Grant) will focus on establishing the ZF as a model for analysis of GBM formation and turnover in the mesonephric kidney under normal conditions and conditions of elevated glucose levels as observed in diabetes. The Specific Aims will include: 1) to determine if isoform switching of BM components occurs during maturation of the ZF mesonephric glomerulus, 2) development of procedures to target expression of GBM components and associated matrix metalloproteinases (MMP5) in the mesonephric kidney of transgenic ZF, 3) to determine if elevated glucose levels result in glycation of proteins in the GBM and if a thickening of the GBM occurs as observed in rodent kidney models, and 4) initiation of experiments using the above mentioned GBM compositional data and transgenic procedures to begin to test the hypothesis that 'GBM thickening in the ZF mesonphric kidney involves a disruption in the normal balance between the polymerization and turnover of matrix components due to non-enzymatic glycation of matrix components that makes them less susceptible to cleavage by MMPs."
描述(由申请人提供):基底膜(BM)增厚

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL Peter SARRAS其他文献

MICHAEL Peter SARRAS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL Peter SARRAS', 18)}}的其他基金

Developing and Improving Institutional Animal Resources at Rosalind Franklin Un.
罗莎琳德·富兰克林大学开发和改善机构动物资源。
  • 批准号:
    7628240
  • 财政年份:
    2009
  • 资助金额:
    $ 15万
  • 项目类别:
Use of Zebrafish as a Model for Diabetic Nephropathy
使用斑马鱼作为糖尿病肾病模型
  • 批准号:
    6622910
  • 财政年份:
    2002
  • 资助金额:
    $ 15万
  • 项目类别:
MODEL FOR GLUCOSE INDUCED BASEMENT MEMBRANE THICKENING
葡萄糖引起的基底膜增厚模型
  • 批准号:
    2147717
  • 财政年份:
    1995
  • 资助金额:
    $ 15万
  • 项目类别:
MODEL FOR GLUCOSE INDUCED BASEMENT MEMBRANE THICKENING
葡萄糖引起的基底膜增厚模型
  • 批准号:
    2734150
  • 财政年份:
    1995
  • 资助金额:
    $ 15万
  • 项目类别:
MODEL FOR GLUCOSE INDUCED BASEMENT MEMBRANE THICKENING
葡萄糖引起的基底膜增厚模型
  • 批准号:
    2147718
  • 财政年份:
    1995
  • 资助金额:
    $ 15万
  • 项目类别:
MODEL FOR GLUCOSE INDUCED BASEMENT MEMBRANE THICKENING
葡萄糖引起的基底膜增厚模型
  • 批准号:
    2444097
  • 财政年份:
    1995
  • 资助金额:
    $ 15万
  • 项目类别:
A MODEL FOR BASEMENT MEMBRANE THICKENING IN DIABETES
糖尿病基底膜增厚的模型
  • 批准号:
    3426184
  • 财政年份:
    1991
  • 资助金额:
    $ 15万
  • 项目类别:
MODEL FOR EPITHELIAL/BASEMENT MEMBRANE INTERACTIONS
上皮/基底膜相互作用模型
  • 批准号:
    2283225
  • 财政年份:
    1990
  • 资助金额:
    $ 15万
  • 项目类别:
MODEL FOR EPITHELIAL/BASEMENT MEMBRANE INTERACTIONS
上皮/基底膜相互作用模型
  • 批准号:
    3421551
  • 财政年份:
    1990
  • 资助金额:
    $ 15万
  • 项目类别:
MODEL FOR EPITHELIAL/BASEMENT MEMBRANE INTERACTIONS
上皮/基底膜相互作用模型
  • 批准号:
    3421548
  • 财政年份:
    1990
  • 资助金额:
    $ 15万
  • 项目类别:

相似海外基金

Complete inhibition of ROCK signaling in diabetic nephropathy
完全抑制糖尿病肾病中的 ROCK 信号传导
  • 批准号:
    23K07709
  • 财政年份:
    2023
  • 资助金额:
    $ 15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a novel therapeutic approach for diabetic nephropathy by nucleic acid medicine (DNA aptamer).
开发核酸药物(DNA 适体)治疗糖尿病肾病的新方法。
  • 批准号:
    23K07732
  • 财政年份:
    2023
  • 资助金额:
    $ 15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Single Cell Landscape of Early Human Diabetic Nephropathy
早期人类糖尿病肾病的单细胞景观
  • 批准号:
    10765844
  • 财政年份:
    2023
  • 资助金额:
    $ 15万
  • 项目类别:
The analysis of the pathophysiology of MR activation-mediated diabetic nephropathy and the exploration of its novel therapeutic approaches.
MR激活介导的糖尿病肾病的病理生理学分析及其新治疗方法的探索。
  • 批准号:
    22K20914
  • 财政年份:
    2022
  • 资助金额:
    $ 15万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Dual Oxidase 2 as a New Target for Treatment of Diabetic Nephropathy
双氧化酶2作为糖尿病肾病治疗新靶点
  • 批准号:
    10624760
  • 财政年份:
    2022
  • 资助金额:
    $ 15万
  • 项目类别:
The gut-renal axis in diabetic nephropathy mediated by segmented filamentous bacteria
分节丝状菌介导的糖尿病肾病肠肾轴
  • 批准号:
    22K17768
  • 财政年份:
    2022
  • 资助金额:
    $ 15万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Dual Oxidase 2 as a New Target for Treatment of Diabetic Nephropathy
双氧化酶2作为糖尿病肾病治疗新靶点
  • 批准号:
    10334036
  • 财政年份:
    2022
  • 资助金额:
    $ 15万
  • 项目类别:
The Single Cell Landscape of Early Human Diabetic Nephropathy
早期人类糖尿病肾病的单细胞景观
  • 批准号:
    10368354
  • 财政年份:
    2022
  • 资助金额:
    $ 15万
  • 项目类别:
Development of a scoring system for predicting diabetic nephropathy severity using urinary podocyte markers.
开发使用尿足细胞标记物预测糖尿病肾病严重程度的评分系统。
  • 批准号:
    22K07448
  • 财政年份:
    2022
  • 资助金额:
    $ 15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cytosine methylation predicts diabetic nephropathy progression
胞嘧啶甲基化预测糖尿病肾病进展
  • 批准号:
    nhmrc : 2003401
  • 财政年份:
    2021
  • 资助金额:
    $ 15万
  • 项目类别:
    Ideas Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了